Biotechnology and Bone Graft Substitutes

Trauma, disease, developmental deformities, and tumor resection frequently cause bone defects that seriously challenge the skills of orthopedic and maxillofacial surgeons. Currently, repairing osseous deficiencies involves various medical surgical techniques, including autogenous grafts, allografts, internal and external fixation devices, electrical stimulation, and alloplastic implants. The existing technology, though effective in many cases, still is beset with numerous difficulties and disadvantages. A critical need for improved treatment methods exists today. Biotechnology now provides access to new bone repair concepts via administration of protein growth and morphogenic factors. Implantable device and drug delivery system technologies also have advanced. The converging biopharmaceutical, device, and delivery technologies represent an opportunity to improve the quality of health care for individuals with orthopedic and maxillofacial deficiencies. This report reviews current concepts in fracture healing and bone repair and examines existing treatment modalities. It also addresses novel protein drugs that stimulate osseous regeneration and delivery systems for these drugs.

[1]  M. Urist,et al.  Bone morphogenesis in implants of insoluble bone gelatin. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Heckman,et al.  The use of bone morphogenetic protein in the treatment of non-union in a canine model. , 1991, The Journal of bone and joint surgery. American volume.

[3]  S Tamai,et al.  Marrow cell induced osteogenesis in porous hydroxyapatite and tricalcium phosphate: a comparative histomorphometric study of ectopic bone formation. , 1990, Journal of biomedical materials research.

[4]  J. Glowacki,et al.  APPLICATION OF THE BIOLOGICAL PRINCIPLE OF INDUCED OSTEOGENESIS FOR CRANIOFACIAL DEFECTS , 1981, The Lancet.

[5]  T Yamamuro,et al.  Bone-fibrin mixture in spinal surgery. , 1992, Clinical orthopaedics and related research.

[6]  M. Noda,et al.  In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.

[7]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988 .

[8]  R. Holmes,et al.  The Induction of Bone by an Osteogenic Protein and the Conduction of Bone by Porous Hydroxyapatite: A Laboratory Study in the Rabbit , 1991, Plastic and reconstructive surgery.

[9]  V. Rosen,et al.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Chapman,et al.  Multicenter Trial of Collagraft as Bone Graft Substitute , 1991, Journal of orthopaedic trauma.

[11]  M. Urist,et al.  Augmentation of spinal fusion with bone morphogenetic protein in dogs. , 1989, Clinical orthopaedics and related research.

[12]  V. Rosen,et al.  Purification and characterization of other distinct bone-inducing factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Hassler,et al.  An evaluation of two configurations of tricalcium phosphate for treating craniotomies. , 1989, Journal of biomedical materials research.

[14]  H. Ohgushi,et al.  Osteogenic capacity of rat and human marrow cells in porous ceramics. Experiments in athymic (nude) mice. , 1990, Acta orthopaedica Scandinavica.

[15]  F. Luyten,et al.  Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. , 1989, The Journal of biological chemistry.

[16]  Michael Jarcho,et al.  Calcium phosphate ceramics as hard tissue prosthetics. , 1981, Clinical orthopaedics and related research.

[17]  M. Urist.  Bone: Formation by Autoinduction , 1965, Science.

[18]  E. E. Johnson,et al.  Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. , 1992, Clinical orthopaedics and related research.

[19]  J. Glowacki,et al.  The use of demineralized xenogeneic bone implants to correct phalangeal defects: a case report. , 1984, The Journal of hand surgery.

[20]  J O Hollinger,et al.  Biodegradable bone repair materials. Synthetic polymers and ceramics. , 1986, Clinical orthopaedics and related research.

[21]  E. J. Miller,et al.  Packaging and delivery of bone induction factors in a collagenous implant. , 1987, Collagen and related research.

[22]  C. Huggins.  THE FORMATION OF BONE UNDER THE INFLUENCE OF EPITHELIUM OF THE URINARY TRACT , 1931 .

[23]  M. Urist,et al.  Solubilized and insolubilized bone morphogenetic protein. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Takaoka,et al.  Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. , 1992, Clinical orthopaedics and related research.

[25]  M. Urist,et al.  Growth factors, mitogens, cytokines, and bone morphogenetic protein in induced chondrogenesis in tissue culture. , 1988, Developmental biology.

[26]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Urist,et al.  Human fibrin is a physiologic delivery system for bone morphogenetic protein. , 1988, Clinical orthopaedics and related research.

[28]  E. E. Johnson,et al.  Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP). , 1990, Clinical orthopaedics and related research.

[29]  E. Wang,et al.  Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. , 1991, Archives of otolaryngology--head & neck surgery.

[30]  J. Lane,et al.  Newest factors in fracture healing. , 1992, Clinical orthopaedics and related research.

[31]  E. Schneiderman,et al.  Osseous regeneration in the presence of four common hemostatic agents. , 1992, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[32]  G. Finerman,et al.  Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. , 1988, Clinical orthopaedics and related research.

[33]  R. Holmes,et al.  A coralline hydroxyapatite bone graft substitute. Preliminary report. , 1984, Clinical orthopaedics and related research.

[34]  W. L. Davis,et al.  Bovine Bone Morphogenetic Protein (bBMP) Fraction‐induced Repair of Craniotomy Defects in the Rhesus Monkey (Macaca speciosa) , 1987, Clinical orthopaedics and related research.

[35]  A. Reddi,et al.  Formation of bone marrow in fibroblast-transformation ossicles. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Reddi,et al.  Calvarial bone regeneration using osteogenin. , 1989, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[37]  Peltier Lf.  The use of plaster of Paris to fill defects in bone. , 1961 .

[38]  R. Salama.  Xenogeneic bone grafting in humans. , 1983, Clinical orthopaedics and related research.

[39]  D J Simmons,et al.  Fracture Healing Perspectives , 1985, Clinical orthopaedics and related research.

[40]  K. Takaoka,et al.  Telopeptide‐depleted bovine skin collagen as a carrier for bone morphogenetic protein , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[41]  L F PELTIER,et al.  The use of plaster of paris to fill large defects in bone. , 1959, American journal of surgery.

[42]  J. Hollinger,et al.  A preliminary study of the osteogenic potential of a biodegradable alloplastic-osteoinductive alloimplant. , 1988, Clinical orthopaedics and related research.

[43]  V. Goldberg,et al.  Heterotopic osteogenesis in porous ceramics induced by marrow cells , 1989, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[44]  J. Hollinger,et al.  Osseous wound healing with xenogeneic bone implants with a biodegradable carrier. , 1990, Surgery.

[45]  E. Amento,et al.  Rapid publication TGF‐β1 induces bone closure of skull defects , 1991 .

[46]  V. Rosen,et al.  The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. , 1992, The Journal of bone and joint surgery. American volume.

[47]  T. Lovell,et al.  Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs. , 1987, Clinical orthopaedics and related research.

[48]  J. Connolly,et al.  Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix. An experimental study in dogs. , 1991, Clinical orthopaedics and related research.

[49]  A. Reddi,et al.  Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Oppermann,et al.  Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. , 1990, The Journal of biological chemistry.

[51]  G. Chen,et al.  Collaboration between Collagenous Matrix and Osteogenin Is Required for Bone Induction , 1990 .